Israeli ingredients group Frutarom reported a drop in profit for the first nine months of the year as sales were affected by the strength of the dollar against European currencies.


Net profit for the nine-month period dropped to US$26.7m from $30.4m in the same period of 2008.


Sales also dropped, falling to $316.7m, a decrease of 4.3% in local currency terms on the prior year. The strengthening of the US dollar compared to most of the European currencies and the NIS caused a decrease in sales in the first nine months of the year at a rate of approximately 11.2%.


Therefore, in US dollar terms, sales slipped by 15.5% compared to the first nine months of 2008


EBITDA totalled $51.5m, which comprises 16.3% of sales compared to $63m, which comprises 16.8% of sales in the first nine months of 2008.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Ori Yehudai, CEO said: “The global crisis changed the growth trend which characterized most of the global markets in recent years. Frutarom entered this challenging and crisis-related period as a leading and strong global company, with a solid capital structure and an experienced global management.”


He added: “Concurrently, we continue to strengthen our R&D and sales infrastructures to ensure the continuation of our profitable growth.”